CLNN 241220 2.00P (CLNN241220P2000) Stock Options, News & Quotes

0.00
0.000.00%

15min DelayTrading Nov 25 09:30 ET

0.00High0.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Trytosaveabit

Nov 13 07:03

Hmm! Update

$Clene (CLNN.US)$ Clene Met With FDA on Nov 1 in Type C Meeting to Discuss Potential for Accelerated Approval Pathway in ALS >CLNN
Dow Jones· just

Trytosaveabit

Oct 23 07:34

Update

$Clene (CLNN.US)$ Clene Inc. unveiled the preliminary design for RESTORE-ALS, a significant Phase 3 clinical trial of their CNM-Au8 30 mg treatment, at the 2024 NEALS Meeting. This development marks a pivotal moment in their research efforts, aiming to bring new treatment options for ALS patients. Investors and market enthusiasts may find this an exciting opportunity as the company progresses in its groundbreaking trial.

soyabean89

Oct 11 09:34

$Clene (CLNN.US)$ wonder it will punch above cloud...dam...

Share Your Profit/Loss

Trytosaveabit

Oct 2 06:37

Update

$Clene (CLNN.US)$ IBN Coverage: Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements
Wed, Oct 2, 2024 at 7:21 AM EDT
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community.
LOS ANGELES, CA - (NewMediaWire) - October 2, 2024 - Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal functio...

SkinnyChick

Aug 6 14:44

$Clene (CLNN.US)$ who tf selling it off??